Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy
2024; Lippincott Williams & Wilkins; Volume: 211; Issue: 4 Linguagem: Inglês
10.1097/ju.0000000000003891
ISSN1527-3792
AutoresTodd M. Morgan, Stephen A. Boorjian, Mark K. Buyyounouski, Brian F. Chapin, David Y.T. Chen, Heather H. Cheng, Roger Chou, Heather A. Jacene, Sophia C. Kamran, Sennett K. Kim, Erin Kirkby, Amy N. Luckenbaugh, B.J. Nathanson, Yaw A. Nyame, Edwin M. Posadas, Phuoc T. Tran, Ronald C. Chen,
Tópico(s)Prostate Cancer Diagnosis and Treatment
ResumoThe summary presented herein covers recommendations on salvage therapy for recurrent prostate cancer intended to facilitate care decisions and aid clinicians in caring for patients who have experienced a recurrence following prior treatment with curative intent. This is Part II of a three-part series focusing on treatment delivery for non-metastatic biochemical recurrence (BCR) after primary radical prostatectomy (RP). Please refer to Part I for discussion of treatment decision-making and Part III for discussion of evaluation and management of recurrence after radiotherapy (RT) and focal therapy, regional recurrence, and oligometastasis.
Referência(s)